The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.50
Bid: 31.00
Ask: 32.00
Change: 0.25 (0.80%)
Spread: 1.00 (3.226%)
Open: 31.25
High: 31.75
Low: 31.25
Prev. Close: 31.25
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2023 Interim Results

1 Dec 2022 07:00

RNS Number : 1645I
Duke Royalty Limited
01 December 2022
 

1 December 2022

Duke Royalty Limited

 

 

("Duke Royalty", "Duke" or the "Company")

 

 

Interim Results for the six months ended 30 September 2022

 

 

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce its interim results for the six-months ended 30 September 2022 ("Interim 2023").

 

Financial Highlights

 

· Total cash revenue* of £10.4 million, up 34% from the prior period (Interim 2022: £7.8 million)

· Recurring cash revenue**, also £10.4 million, increased 67% (Interim 2022: £6.3 million)

· Free cash flow of £6.6 million, up 44% (Interim 2022: £4.6 million)

· Net profit generated of £10.3 million, a 66% increase (Interim 2022: £6.2 million)

· Adjusted earnings of 1.58 pence per share, a 14% increase (Interim 2022: 1.39 pence per share)

· Cash dividends of 1.40 pence per share paid to shareholders, a 27% increase (Interim 2022: 1.10 pence per share)

 

Operational Highlights

 

· Raised £20 million of new equity capital in May 2022

· Deployed over £6 million of capital into existing Royalty Partners

· The portfolio as a whole has proven resilient as trading continues to be in line with expectations during the current macroeconomic headwinds

· During this period of inflation, the portfolio has produced five out of five maximum positive adjustments

· Post period end, invested £5.5 million into new royalty partner New Path Fire & Security

· Currently over £15 million of available liquidity for future deployments

 

* Total cash revenue is monthly cash distributions from Duke's royalty partners plus cash gains received from the sales of equity assets and buyout premiums

** Recurring cash revenue excludes buyout premium receipts and cash gains from equity sales (formerly termed 'normalised' revenue)

 

 

Nigel Birrell, Chairman of Duke Royalty, said:

 

"I am pleased to report that Duke Royalty's results for the six-month period show a continuation of increasing recurring cash revenue and higher cash flow per share metrics, which are both core KPIs for the Company. This strong underlying operating performance allowed Duke to pay two quarterly dividends of 0.70 pence each during Interim 2023, equating to an annualised dividend of 2.80 pence which represents a material increase from the 2.25 pence per share of dividends paid out in FY22. These are pleasing results given the challenging economic and political backdrop globally and the portfolio debt coverage ratio remains comfortable. With this in mind, I would like to thank the Duke team for their ongoing efforts in creating a diversified portfolio of royalty investments that have proven resilient during the current macroeconomic headwinds.

 

"Looking ahead, Duke is well-positioned for growth with additional liquidity ready for deployment. While we have taken a cautious approach to additional deployments in Interim 2023, we feel the current macroeconomic environment will translate to increased demand for our royalty finance solution from profitable, long-standing businesses as we compare favourably to other short term capital solutions. We look forward to expanding our portfolio over the months ahead as we execute on an exciting pipeline of new opportunities which will drive further growth in our business."

 

Investor Webinars

 

Investor Meet Company

 

Neil Johnson, CEO, and Hugo Evans, Finance Director, will deliver a live presentation relating to the Interim Results via the Investor Meet Company platform on Thursday 8 December 2022 at 4pm GMT.

 

The online presentation is open to all existing and potential shareholders.

 

Investors can sign up to Investor Meet Company for free and add to meet Duke Royalty via:

 

https://www.investormeetcompany.com/duke-royalty-limited/register-investor

 

Mello Monday

 

The Company will be presenting at MelloMonday on Monday 12 December 2022, taking place from 5pm to 9.30pm. Both Neil Johnson and Hugo Evans will be presenting and taking questions from participants.

 

If you would like to attend, you can register here for the event.

 

 

 

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

 

+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

+44 (0) 207 397 8900

Canaccord Genuity

(Joint Broker)

 

Adam James / Harry Rees

+44 (0) 207 523 8000

SEC Newgate (Financial Communications)

Elisabeth Cowell /

Axaule Shukanayeva

+ +44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

 

 

CHAIRMAN'S REPORT

 

 

Dear Shareholder,

 

I am pleased to report that Duke Royalty's results for Interim 2023 show a continuation of increasing recurring cash revenue and higher cash flow per share metrics, which are both core KPIs for the Company. These are pleasing results given the challenging economic and political backdrop globally. With this in mind, I would like to thank the Duke team for their ongoing efforts in creating a diversified portfolio of royalty investments that have proven resilient during the current macroeconomic headwinds.

 

I note that there has only been a short period since the Company released its full year results for the 12 months ended 31 March 2022 ("FY 2022"). However, in this short period we have witnessed two different UK Prime Ministers, an escalation in the Russia/Ukraine conflict, significantly higher interest rates and more mainstream commentary about the possible onset of a global recession. Against this undeniably bearish market backdrop, Duke has continued to selectively deploy its capital and will continue to be opportunistic at a time when other lenders are pulling back from the market, thereby providing an opportunity for Duke to expand and increase its market share.

 

Duke's simple investment philosophy of providing long dated, senior secured royalty investments to established and profitable SME owner-operated business will see it through these challenging times, and I am pleased to report a strong set of financial results for Interim 2023 alongside an optimistic outlook for the rest of the financial year.

 

Operational Review

 

In May 2022, Duke announced a £20 million equity placing from both institutional and retail investors. Net proceeds from this fundraising were used to repay the existing debt and provide additional liquidity headroom, allowing the Company both to invest further capital into its existing Royalty Partners as well into new opportunities. In that regard, Duke invested £6.6m into Intec and Tristone during Interim 2023, both of which are undertaking buy and build strategies in their respective sectors of I.T. managed services and specialist residential and domiciliary care. However, given the volatile macroeconomic back drop, the general feeling in the period was one of caution whilst positioning the Company to take advantage of an ever-expanding deal pipeline and market opportunity.

 

Based on our current deal pipeline, we expect to deliver an acceleration in deployments over the next six months, and I am pleased to note that Duke had £21m of liquidity available for deployment into this pipeline of new deal opportunities at 30 September 2022. In that regard, post period end the Company announced a £5.5 million new deployment into New Path Fire & Security, a specialist Fire and Security business, that is undertaking a buy and build strategy in the highly fragmented Fire and Security sector. I look forward to announcing further follow-on investments into New Path Fire in due course as they execute on their business plan.

 

In terms of the existing portfolio, a further five positive adjustment resets have been recorded in the first six months of the financial year, driven by the current high levels of inflation which have increased the average yield on the Duke portfolio to record levels. These positive resets, when taken alongside a period of high deployment in FY 2022, has allowed Duke to continue to announce record consecutive quarters of recurring cash revenue during Interim 2023, a trend we again expect to continue in the coming quarters. Clearly the current falling levels of discretionary consumer spending remain a key area of focus for the Company but in general, Duke's stated focus on investing in B2B businesses has meant that this has had less of a direct impact. To date, the Company's portfolio as a whole continues to trade robustly. In that regard, it is pleasing to note that the portfolio debt service coverage ratio remains at a level above 2x, thereby providing a good degree of insulation during these volatile times. As previously discussed in prior Chairman's Statements, as Duke deploys more capital the ongoing advantages of operational leverage will increasingly benefit shareholders and this is a trend that I look forward to reporting on in future periods.

 

Financial Review

 

The financial results for Interim 2023 reflect the resilience of Duke's business model and its ability to withstand stresses in the global financial system. I am delighted to report that the Company's cash revenue, being cash distributions from Royalty Partners and cash gains from the sale of equity investments, grew to £10.4 million during the Period under review, a 34% increase over the £7.8 million generated in Interim 2022. However, it should be noted that Interim 2022 benefited from the BHP buyout, which delivered over £1.5 million of premiums and realised equity gains. On a like-for-like basis, Interim 2023 produced £10.4 million of recurring cash revenue against £6.2 million in FY 2022, a 67% increase.

 

Free cash flow, which represents the Company's ability to pay out quarterly cash dividends to its shareholders and is defined as net operating cash inflow plus cash gains from the sale of equity investments less its interest on debt financing, grew by 27% to £6.6 million. This equates to 1.71 pence per share, up from £4.6 million and 1.36 pence per share in Interim 2022.

 

Total income, which includes non-cash fair value movements on the Company's investment portfolio, grew to £15.8 million, a 62% increase over Interim 2022. This generated total earnings after tax of £10.3 million and earnings per share of 2.65 pence against £6.2 million in Interim 2022 and earnings per share of 1.84 pence. Adjusted earnings, which strips out the fair value movements and represents a truer reflection of Duke's operating performance, rose to £6.2 million from £4.7 million, a 32% increase.

 

Dividend

 

This strong underlying operating performance allowed Duke to pay two quarterly dividends of 0.70 pence each during Interim 2023, equating to an annualised dividend of 2.80 pence which represents a material increase from the 2.25 pence per share of dividends paid out in FY22. It is pleasing to note that at the current 2.80 pence annualised rate, the dividend is well covered by free cash flow, and it is the intention of Duke to increase its dividend at a measured pace over time while at the same time reducing the Company's payout ratio, thereby allowing more cash to be reinvested into new deal opportunities.

 

Outlook

 

Duke is well-positioned for growth having created a large and diversified portfolio of royalty investments, an exciting pipeline of new opportunities and a strong liquidity position ready for deployment. Additionally, the current macroeconomic climate means that demand for our solution from profitable, long-standing businesses, is as high as ever.

 

As always, I am appreciative of the ongoing support of our shareholders and am pleased to report the Chairman's Statement for Interim 2023. Our existing partners have traded resiliently during the period and the Group's business model is well insulated to withstand the current economic headwinds and to grow its market share.

 

I look forward to reporting on the Group's ongoing progress and development in future periods.

 

 

Nigel Birrell

Chairman

 

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

 

Period to

Year to

Period to

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

Cash flows from operating activities

Receipts from royalty investments

10,234

14,701

 6,419

Receipts of interest from loan investments

173

580

 450

Other operating income

30

543

 266

Operating expenses paid

(1,061)

(2,487)

(946)

Payments for royalty participation fees

(57)

(115)

(57)

Tax paid

(813)

(2,055)

(1,569)

Net cash inflow from operating activities

8,506

11,167

4,563

Cash flows from investing activities

Royalty investments advanced

(6,550)

(74,586)

(23,209)

Royalty investments received

-

2,938

 2,938

Loan investments advanced

(700)

(3,192)

 - 

Loan investments received

-

3,949

 3,370

Equity investments advanced

-

(530)

(530)

Receipts from equity instruments

-

300

 652

Realised gain from sale of equity investments

-

2,583

-

Receipt of deferred consideration

-

7,679

-

Investment costs paid

(173)

(972)

(496)

Net cash outflow from investing activities

(7,423)

(61,831)

(17,275)

Cash flows from financing activities

Proceeds from share issue

20,000

35,000

 35,000

Share issue costs

(1,115)

(1,936)

(1,936)

Dividends paid

(5,282)

(7,270)

(3,270)

Proceeds from loans

5,050

38,200

 - 

Loan repaid

(18,500)

(7,500)

(7,500)

Interest paid

(1,872)

(1,649)

(612)

Other finance costs paid

(30)

(181)

 - 

Net cash (outflow) / inflow financing activities

(1,749)

54,664

21,682

Net change in cash and cash equivalents

(666)

4,000

8,970

Cash and cash equivalents at beginning of period/year

5,707

1,766

1,766

Effect of foreign exchange on cash

31

(59)

9

Cash and cash equivalents at the end of period/year

5,072

5,707

10,745

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF INCOME

 

Period to

Year to

Period to

30-Sep-22

31-Mar-22

30-Sep-21

Note

(unaudited)

(audited)

(unaudited)

£000

£000

£000

Income

Royalty investment net income

6

15,079

18,037

 7,584

Loan investment net income

7

173

533

 410

Equity investment net income

8

485

9,678

 1,497

Other operating income

30

543

 266

Total income

15,767

28,791

 9,757

Investment Costs

Transaction costs

(28)

(631)

(525)

Due diligence costs

(455)

(1,113)

 11

Total Investment Costs

(483)

(1,744)

(514)

Operating Costs

Administration and personnel

(1,811)

(2,060)

(1,191)

Legal and professional

(232)

(405)

(183)

Other operating expenses

(100)

(151)

(65)

Expected credit losses

-

(72)

-

Share-based payments

(458)

(930)

(472)

Total operating costs

(2,601)

(3,618)

(1,911)

Operating profit

12,683

23,429

 7,332

Net foreign currency gains

177

(60)

 108

Finance costs

3

(1,951)

(1,996)

(693)

Profit for the period before tax

10,909

21,373

 6,747

Taxation expense

4

(614)

(982)

(540)

Total comprehensive income for the period

10,295

20,391

 6,207

Basic earnings per share (pence)

5

2.65

5.95

1.84

Diluted earnings per share (pence)

5

2.65

5.95

1.84

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

Note

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

Non-current assets

Goodwill

13

203

203

 203

Royalty finance investments

6

149,853

139,648

 93,232

Loan investments

7

3,872

3,172

 1,000

Equity investments

8

11,305

10,820

 4,810

Trade and other receivables

10

-

2,141

 2,236

Deferred tax asset

18

155

156

 157

165,388

156,140

 101,638

Current assets

 

Royalty finance investments

6

22,091

20,831

 13,607

Loan investments

7

1,000

1,000

 580

Equity investments

8

-

-

 60

Trade and other receivables

10

2,294

53

 7,780

Cash and cash equivalents

5,072

5,707

 10,745

Current tax asset

111

 -

 -

30,568

27,591

 32,772

 

Total Assets

195,956

183,731

 134,410

 

Current liabilities

 

Royalty debt liabilities

9

165

160

 144

Trade and other payables

11

1,423

423

 868

Borrowings

12

337

362

 172

Current tax liability

-

87

 132

1,925

1,032

 1,316

Non-current liabilities

 

Royalty debt liabilities

9

960

951

 932

Trade and other payables

11

1,331

1,067

 204

Borrowings

12

34,363

47,740

 9,659

36,654

49,758

 10,795

 

Net Assets

157,377

132,941

 122,299

 

Equity

 

Shares issued

14

172,939

153,974

 153,974

Share based payment reserve

15

2,936

2,478

 2,020

Warrant reserve

15

265

265

 265

Retained losses

16

(18,763)

(23,776)

(33,960)

 

Total Equity

157,377

132,941

 122,299

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Share-based

Shares

payment

Warrant

Retained

Total

Note

issued

reserve

reserve

losses

equity

£000

£000

£000

£000

£000

At 1 April 2021

 120,870

 1,548

 265

(36,897)

 85,786

Total comprehensive income for the period

 - 

 - 

 - 

 6,207

6,207

Transactions with owners

Shares issued for cash

 35,000

 - 

 - 

 - 

 35,000

Share issuance costs

(1,936)

 - 

 - 

 - 

(1,936)

Share based payments

 40

 472

 - 

 - 

 512

Dividends

 - 

 - 

 - 

(3,270)

(3,270)

Total transactions with owners

 33,104

 472

 -

(3,270)

 30,306

At 30 September 2022

 153,974

 2,020

 265

(33,960)

 122,299

Total comprehensive income for the period

-

-

-

14,184

14,184

Transactions with owners

Share based payments

 -

 458

 -

 -

458

Dividends

 -

 -

 -

(4,000)

(4,000)

Total transactions with owners

-

 458

 -

(4,000)

(3,542)

At 31 March 2022

153,974

2,478

 265

(23,776)

132,941

 

 

Share-based

Shares

payment

Warrant

Retained

Total

Note

issued

reserve

reserve

losses

equity

£000

£000

£000

£000

£000

At 1 April 2022

153,974

2,478

 265

(23,776)

132,941

Total comprehensive income for the period

 -

 -

 -

 10,295

10,295

Transactions with owners

Shares issued for cash

 20,000

 -

 -

 -

 20,000

Share issuance costs

(1,115)

 -

 -

 -

(1,115)

Share based payments

 80

 458

 -

 -

 538

Dividends

 -

 -

 -

(5,282)

(5,282)

Total transactions with owners

 18,965

 458

 -

(5,282)

 14,141

At 30 September 2022

 172,939

 2,936

 265

(18,763)

157,377

 

NOTES TO THE FINANCIAL STATEMENTS

 

1. General Information

 

Duke Royalty Limited ("Duke Royalty" or the "Company") is a company limited by shares, incorporated in Guernsey under the Companies (Guernsey) Law, 2008. Its shares are traded on the AIM market of the London Stock Exchange.

 

Throughout the period, the "Group" comprised Duke Royalty Limited and its wholly owned subsidiaries; Duke Royalty UK Limited, Capital Step Holdings Limited, Capital Step Investments Limited, Capital Step Funding Limited, Capital Step Funding 2 Limited and Duke Royalty Employee Benefit Trust.

 

The Group's investing policy is to invest in a diversified portfolio of royalty finance and related opportunities.

 

2. Significant accounting policies

 

2.1 Basis of preparation

 

The interim Condensed Consolidated Financial Statements of the Group have been prepared in accordance with UK adopted international accounting standards, and applicable Guernsey law, and reflect the following policies, which have been adopted and applied consistently.

 

On 31 December 2020, IFRS as adopted by the European Union at that date was brought into the UK law and became UK-adopted international accounting standards, with future changes being subject to endorsement by the UK Endorsement Board. The group transitioned to UK-adopted international accounting standards in its consolidated financial statements on 1 April 2021. There was no impact or changes in accounting from the transition.

 

The accounting policies adopted in the preparation of the interim Condensed Consolidated Financial Statements are consistent with those followed in the preparation of the Consolidated Financial Statements of the Group for the year ended 31 March 2022.

 

The Financial Statements have been prepared on a historical cost basis, except for the following:

 

· Royalty investments - measured at fair value through profit or loss

· Equity investments - measured at fair value through profit or loss

· Royalty participation liabilities - measured at fair value through profit or loss

 

The Directors consider that the Group has adequate financial resources to enable it to continue operations for a period of no less than 12 months from the date of approval of the financial statements. Accordingly, the Directors believe that it is appropriate to continue to adopt the going concern basis in preparing the financial statements.

 

2.2 New and amended standards adopted by the Group

 

There were no new standards adopted by the Group during the reporting period.

 

2.3 New standards and interpretations not yet adopted

 

At the date of authorisation of these interim Condensed Consolidated Financial Statements, certain standards and interpretations were in issue but not yet effective and have not been applied in these interim Condensed Consolidated Financial Statements. The Directors do not expect that the adoption of these standards and interpretations will have a material impact on the interim Condensed Consolidated Financial Statements of the Group in future periods.

 

2.4 Going concern

 

In assessing the going concern basis of accounting the Directors have had regard to the guidance issued by the Financial Reporting Council. After making enquiries and bearing in mind the nature of the Company's business and assets, the Directors consider that the Company has adequate resources to continue in operational existence for the foreseeable future.

 

The cash flow needs of the Group have been assessed taking account the need for further funding for any of the existing royalty partners and the ongoing working capital needs of the business against the current cash and liquidity of the Group.

 

Furthermore, there is adequate headroom in terms of the uncalled loan facility in place should it be required.

 

 

3. Finance Costs

 

Period to

 

Year to

Period to

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Interest payable on borrowings

 1,750

1,499

409

Non-utilisation fees

 112

350

213

Deferred finance costs released to P&L

 89

147

71

 1,951

 

1,996

 

693

 

 

4. Income tax

 

The Company has been granted exemption from Guernsey taxation. The Company's subsidiary in the UK is subject to taxation in accordance with relevant tax legislation.

 

Period to

 

Year to

Period to

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

Current tax

Income tax expense

613

980

539

 

Deferred tax

 

Decrease in deferred tax assets

1

3

2

Decrease in deferred tax liabilities

-

(1)

(1)

1

2

1

 

Income tax expense

614

982

540

 

 

Factors affecting income tax expense for the period

 

Period to

 

Year to

Period to

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Profit on ordinary activities before tax

10,910

21,373

6,747

 

Tax using the Groups effective tax rate of 5.63% (2022: 4.60%, period to 30 September 2022: 8.00%)

614

982

540

Income tax expense

614

982

540

 

 

5. Earnings per share

Period to

 

Year to

Period to

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Total comprehensive income (£000)

10,295

20,391

6,207

Weighted average number of Ordinary Shares in issue, excluding treasury shares (000s)

388,412

342,822

337,310

Basic earnings per share (pence)

2.65

5.95

1.84

 

Period to

 

Year to

Period to

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Total comprehensive income (£000)

10,295

20,391

6,207

Weighted average number of Ordinary Shares, diluted for warrants in issue (000s)

388,412

342,822

337,310

Diluted earnings per share (pence)

2.65

5.95

1.84

 

 

Basic earnings per share is calculated by dividing total comprehensive income for the period by the weighted average number of shares in issue throughout the period, excluding treasury shares (see Note 14). Diluted earnings per share represents the basic earnings per share adjusted for the effect of dilutive potential shares issuable on exercise of share options under the Company's share-based payment schemes, weighted for the relevant period.

 

All share options, warrants and Long-Term Incentive Plan awards in issue are not dilutive at the year-end as the exercise prices were above the average share price for the period. However, these could become dilutive in future periods.

 

Adjusted earnings per share

 

Adjusted earnings represent the Group's underlying performance from core activities. Adjusted earnings is the total comprehensive income adjusted for unrealised and non-core fair value movements, non-cash items and transaction-related costs, including due diligence fees, together with the tax effects thereon. Given the sensitivity of the inputs used to determine the fair value of its investments, the Group believes that adjusted earnings is a better reflection of its ongoing financial performance.

 

Valuation and other non-cash movements such as those outlined are not considered by management in assessing the level of profit and cash generation of the Group. Additionally, IFRS 9 requires transaction-related costs to be expensed immediately whilst the income benefit is over the life of the asset. As such, an adjusted earnings measure is used which reflects the underlying contribution from the Group's core activities during the year.

 

Period to

 

Year to

Period to

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Total comprehensive income for the period

 10,295

20,391

 6,207

 

Unrealised fair value movements

(5,330)

(10,431)

(2,663)

Expected credit losses

-

72

-

Share-based payments

 458

930

 472

Investment costs

483

1,746

 525

Tax effect of the adjustments above at Group effective rate

247

350

 134

Adjusted earnings

6,153

13,058

4,675

 

Period to

 

Year to

Period to

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Adjusted earnings for the year (£000)

6,153

13,058

4,675

Weighted average number of Ordinary Shares in issue, excluding treasury shares (000s)

388,412

342,822

337,310

Adjusted earnings per share (pence)

1.58

3.81

1.39

 

 

Period to

 

Year to

Period to

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Diluted adjusted earnings for the year (£000)

6,153

13,058

4,675

Diluted weighted average number of Ordinary Shares in issue, excluding treasury shares (000s)

388,412

342,822

337,310

Diluted adjusted earnings per share (pence)

1.58

3.81

1.39

 

 

6. Royalty investments

 

Royalty investments are financial assets held at FVTPL that relate to the provision of royalty capital to a diversified portfolio of companies.

 

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Brought forward

 160,479

 85,301

85,301

Additions

 6,550

 74,586

23,209

Refinanced assets

 -

(2,939)

(2,938)

Gain on financial assets at FVTPL

 4,915

 3,531

1,267

 171,944

 160,479

106,839

 

Royalty finance investments are comprised of:

 

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Non-Current

149,853

139,648

93,232

Current

22,091

20,831

13,607

171,944

160,479

106,839

 

 

Royalty investment net income on the face of the consolidated statement of comprehensive income comprises:

 

Period to

 

Year to

Period to

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Royalty interest

10,234

13,987

5,705

Royalty premiums

-

714

714

Gain on royalty assets at FVTPL

4,916

3,531

1,267

Loss on royalty liabilities at FVTPL

(71)

(195)

(102)

15,079

18,037

7,584

 

All financial assets held at FVTPL are mandatorily measured as such.

 

The Group's royalty investment assets comprise royalty financing agreements with 13 (30 September 2021: 11, 31 March 2022: 13) investees. Under the terms of these agreements the Group advances funds in exchange for annualised royalty distributions. The distributions are adjusted based on the change in the investees' revenues, subject to a floor and a cap. The financing is secured by way of fixed and floating charges over certain of the investees' assets. The investees are provided with buyback options, exercisable at certain stages of the agreements.

 

7. Loan investments

 

Loan investments are financial assets held at amortised cost which the exception of the £2.2 million loan issued at 0% interest. The impact of discounting is immaterial to the financial statements. The below table shows both the loans at amortised cost and fair value.

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Brought forward

4,172

4,950

4,950

Additions

700

3,192

-

Buybacks

-

(3,950)

(3,370)

Expected credit losses

-

(20)

 

4,872

4,172

1,580

 

The Group's loan investments comprise secured loans advanced to two entities (30 September 2021: two, 31 March 2022: two) in connection with the Group's royalty investments.

 

The loans comprise fixed rate loans of £4,872,000 (30 September 2021: £1,580,000, March 2022: £4,172,000) which bear interest at rates of between 0% and 15%.

 

The loans mature as follows:

 

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

In less than one year

1,000

1,000

580

In one to two years

-

-

-

In two to five years

3,872

3,172

1,000

4,872

4,172

1,580

 

Loan investment net income on the face of the consolidated statement of comprehensive income comprises:

 

Period to

 

Year to

Period to

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Loan interest

173

533

410

 

ECL Analysis

 

The measurement of ECLs is primarily based on the product of the instrument's probability of default ("PD"), loss given default ("LGD"), and exposure at default ("EAD"). The Group analyses a range of factors to determine the credit risk of each investment. These include, but are not limited to:

 

· liquidity and cash flows of the underlying businesses

· security strength

· covenant cover

· balance sheet strength

 

If there is a material change in these factors, the weighting of either the PD, LGD or EAD increases, thereby increasing the ECL impairment.

 

The disclosure below presents the gross and net carrying value of the Group' loan investments by stage:

 

Gross carrying amount

 

Allowance for ECLs

Net

Carrying amount

As at 30 September 2022

£000

£000

£000

 

Stage 1

4,872

 

-

 

4,872

Stage 2

-

 

-

 

-

Stage 3

-

 

-

 

-

4,872

 

-

 

4,872

 

 

Gross carrying amount

Allowance for ECLs

Net

Carrying amount

As at 31 March 2022

£000

£000

£000

Stage 1

4,192

(20)

4,172

Stage 2

-

-

-

Stage 3

-

-

-

4,192

(20)

4,172

 

Gross carrying amount

Allowance for ECLs

Net

Carrying amount

As at 30 September 2022

£000

£000

£000

Stage 1

1,580

-

1,580

Stage 2

 -

-

 -

Stage 3

-

-

-

1,580

-

1,580

 

Under the ECL model introduced by IFRS 9, impairment provisions are driven by changes in credit risk of instruments, with a provision for lifetime expected credit losses recognised where the risk of default of an instrument has increased significantly since initial recognition.

 

The credit risk profile of the investments has not increased materially and they remain Stage 1 assets. No ECLs have been charged in the period on these assets as they are not deemed material.

 

The following table analyses Group's provision for ECL's by stage for the period ended 30 September 2022:

 

Stage 1

 

Stage 2

 

Stage 3

 

Total

 

£000

 

£000

 

£000

 

£000

 

 

 

 

 

 

 

At 1 April 2021 and 30 September 2021

-

-

-

-

Expected credit losses on loan investments in year

20

-

-

20

Expected credit losses on other receivables in year

52

-

-

52

Carrying value at 31 March 2022 and 30 September 2022

72

-

-

72

 

 

8. Equity investments

 

Equity investments are financial assets held at FVTPL.

 

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

Brought forward

10,820

3,495

 3,495

Additions

-

530

 530

Disposals

-

(2,883)

(652)

Gain / (loss) on equity assets held at FVTPL

485

9,678

 1,497

11,305

10,820

 4,870

 

The Group's equity investments comprise unlisted shares and warrants in 10 of its royalty investment companies (30 September 2021: eight, 31 March 2022: nine).

 

The Group also still holds two (30 September 2021: two, 31 March 2022: two) unlisted investments in mining entities from its previous investment objectives. The Board does not consider there to be any future cash flows from the remaining investments and they are fully written down to nil value.

 

Equity investment net income on the face of the consolidated statement of comprehensive income comprises:

 

Period to

 

Year to

Period to

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

Gain / (loss) on equity investments at FVTPL

485

7,095

1,497

Realised gain on sale of equity investments

-

2,583

-

485

9,678

1,497

 

 

9. Royalty debt liabilities

 

Royalty debt liabilities are financial liabilities held at FVTPL.

 

30-Sep-22

 

31-Mar-22

30-Sep-21

(unaudited)

 

(audited)

(unaudited)

 

£000

£000

£000

 

Brought forward

1,111

1,031

 1,031

Payments made

(57)

(115)

(57)

Loss on financial assets held at FVTPL

71

195

102

1,125

1,111

 1,076

 

Royalty debt liabilities are comprised of:

 

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

 

Current

165

160

144

Non-current

960

951

932

1,125

1,111

1,076

 

 

10. Trade and other receivables

 

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

Current

Prepayments and accrued income

8

53

43

Other receivables

2,286

-

7,737

2,294

53

7,780

Non-current

 

Other receivables

-

2,141

2,236

 

2,294

2,194

10,016

 

 

The other receivable balance consists of funds due on the sale of Duke Royalty Switzerland Gmbh, incorporated to hold the riverboat assets. On 31 March 2021, Duke sold its Swiss subsidiary to Starling Fleet AG for €11,600,000. The deal was structured so that €5,000,000 was payable on or before 30 September 2021, €4,000,000 was due on or before 30 September 2022, with the remaining €2,600,000 due on or before 30 June 2023. The second instalment of €4,000,000 was repaid early in March 2022. The last instalment is classified as current.

 

Using the same methodology as laid out in note 7 for the loan investments, the deferred consideration has been subject to ECL impairment. The financial strength of the counterparty has been reviewed in conjunction with current and future outlook for river cruising, while also taking into account the charges that the Group owns over the riverboats. An ECL impairment of £52,000 was recognised against this asset in the year to 31 March 20022 (refer to Note 10 for classification). No further impairment was recognised in the period to 30 September 2022.

 

11. Trade and other payables

 

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

Current

Trade payables

8

11

10

Transaction costs

279

233

125

Accruals and deferred income

1,136

179

733

1,423

423

868

Non-current

 

Transaction costs

1,331

1,067

 

204

 

2,754

1,490

1,072

 

 

12. Borrowings

 

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

Secured loan

 

Current - accrued interest

337

362

172

Non-current

34,363

47,740

9,659

34,700

48,102

9,831

 

The secured loan facility has an interest rate of 7.25% over one-month UK LIBOR per annum. In January 2022, the facility term was extended and the facility size increased from £35,000,000 to £55,000,000. Of this, £35,000,000 comprised a revolving facility and £20,000,000 a term facility. The principal amount is repayable on 18 January 2027. Furthermore, the interest rate was amended to 7.25% over SONIA. The loan is secured by means of a fixed and floating charge over the assets of the Group.

 

The Group has adopted Interest Rate Benchmark Reform - IBOR 'phase 2' (Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and 16). Applying the practical expedient introduced by the amendments, when the benchmarks affecting the Group's loans are replaced, the adjustments to the contractual cash flows will be reflected as an adjustment to the effective interest rate. Therefore, the replacement of the loans' benchmark interest rate will not result in an immediate gain or loss recorded in profit or loss, which may have been required if the practical expedient was not available or adopted.

 

As at 30 September 2022, £20,250,000 was undrawn on the facility (30 September 2021: £25,000,000, 31 March 2022: £6,800,000).

 

At 30 September 2022, £387,000 (30 September 2021: £355,000, 31 March 2022: £460,000) of unamortised fees remained outstanding.

 

The table below set out an analysis of net debt and the movements in net debt for the period ended 30 September 2022, the prior period and the year ended 31 March 2022.

 

 

Interest Payable

 

Borrowings

 

£000

 

£000

 

 

 

 

At 1 April 2022

362

 

47,740

 

 

 

 

Cash movements

 

 

 

Loan advanced

-

 

5,050

Loan repaid

-

 

(18,500)

Deferred finance costs paid

-

 

-

Interest paid

(1,872)

 

-

Other finance costs paid

(30)

 

 

Non-cash movements

 

 

 

Deferred finance costs released to P&L

-

 

73

Interest charged

1,862

 

-

Other finance costs charged

15

 

-

As at 30 September 2022

337

 

34,363

 

Interest Payable

 

Borrowings

 

£000

 

£000

 

 

 

 

At 1 April 2021

161

17,103

Cash movements

Loan repaid

-

(7,500)

Interest paid

(611)

-

Non-cash movements

Deferred finance costs released to P&L

-

56

Interest charged

622

-

As at 30 September 2021

172

9,659

 

Cash movements

 

 

 

Loan advanced

-

38,200

Deferred finance costs paid

-

(181)

Interest paid

(1,038)

 - 

Non-cash movements

 

 

 

Deferred finance costs released to P&L

-

62

Interest charged

1,228

-

As at 31 March 2022

362

47,740

 

 

13. Goodwill

 

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

 

Goodwill arising on business combination

203

203

203

 

14. Share capital

 

External Shares

No.

 

Treasury Shares

No.

 

Total shares

No.

£000

Allotted, called up and fully paid

 

 

 

 

 

 

At 31 March 2021

247,052

10,855

257,907

120,870

Shares issued for cash during the period

100,000

-

100,000

35,000

Share issuance costs

-

-

-

(1,936)

Shares issued to directors and key advisers as remuneration

105

-

105

40

At 30 September 2021

347,157

10,855

358,012

153,974

Shares issued to Employee Benefit Trust during the period

-

792

792

-

PSA shares vested during the year

1,457

(1,457)

-

-

At 31 March 2022

348,614

10,190

358,804

153,974

 

 

 

 

 

 

 

Shares issued for cash during the period

57,143

 

-

 

57,143

 

20,000

Share issuance costs

-

 

-

 

-

 

(1,115)

Shares issued to directors and key advisers as remuneration

205

 

-

 

205

 

80

At 31 September 2021

405,962

 

10,190

 

416,152

 

172,939

 

 

There is a single class of shares. There are no restrictions on the distribution of dividends and the repayment of capital with respect to externally held shares. The shares held by the Duke Royalty Employee Benefit Trust are treated as treasury shares. The rights to dividends and voting rights have been waived in respect of these shares.

 

 

15. Equity-settled share-based payments

 

Warrant reserve

 

There were no movements in the warrant reserve during the period:

 

Warrants

 

No. (000)

 

£000

 

 

 

At 1 April 2021, 30 September 2021, 31 March 2022, and 30 September 2022

4,375

265

 

At 30 September 2022, 4,375,000 (30 September 2021: 4,375,000, 31 March 20212 4,375,000) warrants were outstanding and exercisable at a weighted average exercise price of 46 pence (30 September 2021: 46 pence, 31 March 2022: 46 pence). The weighted average remaining contractual life of the warrants outstanding was 0.50 years (30 September 2021: 1.50 years, 31 March 2022: 1.00 years).

 

Share-based payment reserve

 

The following table shows the movements in the share-based payment reserve during the period:

 

 

Share options

 

LTIP

 

Total

 

£000

 

£000

 

£000

 

 

 

 

 

 

At 1 April 2021 and 30 September 2021

136

1,412

1,548

LTIP awards

-

472

472

At 30 September 2021

136

1,884

2,020

 

 

 

LTIP awards

-

458

458

At 31 March 2022

136

2,342

2,478

 

 

 

LTIP awards

-

 

458

458

At 30 September 2022

136

 

2,800

2,936

 

Share option scheme

 

No share options were granted during the period to 30 September 2022.

 

At 30 September 2022, 200,000 options (30 September 2021: 960,000, 31 March 2022: 200,000) were outstanding and exercisable at a weighted average exercise price of 50 pence (30 September 2021: 31 March 2022: 50 pence). The weighted average remaining contractual life of the options outstanding at the period end was 1.00 years (30 September 2021: 2.00 years, 31 March 2022: 1.50 years).

 

Long Term Incentive Plan

 

No performance share awards (PSAs) were granted during the period to 30 September 2022.

 

At 30 September 2022, 12,298,000 (30 September 2021: 11,855,000, 31 March 2022: 12,298,000) PSAs were outstanding. The weighted average remaining vesting period of these awards outstanding was 1.00 year (30 September 2021: 1.44 years, 31 March 2022: 1.50 years).

 

16. Distributable reserves

 

Under Guernsey law, the Company can pay dividends provided it satisfies the solvency test prescribed by the Companies (Guernsey) Law, 2008. The solvency test considers whether the Company is able to pay its debts when they fall due, and whether the value of the Company's assets is greater than its liabilities. The Company satisfied the solvency test in respect of the dividends declared in the period.

 

17. Dividends

 

The following interim dividends have been recorded in the period to 30 September 2022, 31 March 2022 and 30 September 2021:

 

 

Dividend per

 

Dividends

 

share

 

payable

Record date

Payment date

pence/share

 

£000

 

 

 

 

 

26 March 2021

12 April 2021

0.55

1,359

25 June 2021

12 July 2021

0.55

1,909

Dividends paid for the period ended 30 September 2021

3,268

 

 

 

Dividend per

 

Dividends

 

share

 

payable

Record date

Payment date

pence/share

 

£000

 

 

 

 

 

24 September 2021

12 October 2021

0.55

1,909

24 December 2021

12 January 2022

0.60

2,093

Dividends paid for the period ended 31 March 2022

4,702

 

 

 

 

25 March 2022

12 April 2022

0.70

 

2,440

1 July 2022

12 July 2022

0.70

 

2,842

Dividends paid for the period ended 30 September 2022

 

5,282

 

On 30 September 2022 the Company approved a further quarterly cash dividend of 0.70 pence per share, totalling £2,8420,000, which was paid on 12 October 2021.

 

18. Deferred tax

 

 

Total

 

£000s

 

 

1 April 2021

158

Credited / (charged) to profit & loss

(1)

At 30 September 2021

157

Credited / (charged) to profit & loss

(1)

At 31 March 2022

156

Charged to profit & loss

(1)

At 30 September 2022

155

 

 

The deferred tax asset arises due to a temporary timing differences on the treatment of transaction costs in the UK subsidiary. This deferred tax asset is expected to reverse over a 30 year period. The utilisation of this asset is dependent on sufficient future taxable profits being generated by the UK subsidiary.

 

 

19. Related parties

 

Directors' fees

 

The following fees were payable to the Directors during the period:

 

 

Period to

 

Year to

Period to

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

 

 

Short term remuneration

734

730

463

Share-based payments

211

485

273

945

1,215

736

 

Other related party transactions

 

The following amounts were paid to related parties during the period in respect of support services fees:

 

Period to

 

Year to

Period to

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

 

 

Abingdon Capital Corporation

205

363

175

Arlington Group Asset Management Limited

43

85

43

248

448

218

 

 

Support Service Agreements with Abingdon Capital Corporation ("Abingdon"), a company of which Neil Johnson is a Director, and Arlington Group Asset Management Limited ("Arlington"), a company of which Charles Cannon Brookes is a Director, were signed on 16 June 2015. The services to be provided by both Abingdon and Arlington include global deal origination, vertical partner relationships, office rental and assisting the Board with the selection, execution and monitoring of royalty partners and royalty performance. Abingdon fees also includes fees relating to remuneration of staff residing in North America.

 

Dividends

 

The following dividends were paid to related parties:

 

Period to

 

Year to

Period to

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

 

 

Directors 1

186

262

124

Other related parties

27

37

17

213

299

141

 

1 Includes dividends paid to Abinvest Corporation, a wholly owned subsidiary of Abingdon Capital Corporation, and to Arlington Group Asset Management

 

 

20. Fair value measurements

 

Fair value hierarchy

 

IFRS 13 requires disclosure of fair value measurements by level of the following fair value hierarchy:

 

Level 1: Inputs are quoted prices (unadjusted) in active markets for identical assets and liabilities that the entity can readily observe.

 

Level 2: Inputs are inputs other than quoted prices included within Level 1 that are observable for the asset, either directly or indirectly.

 

Level 3: Inputs that are not based on observable market date (unobservable inputs).

 

The Group has classified its financial instruments into the three levels prescribed as follows:

 

 

30-Sep-22

31-Mar-22

30-Sep-21

(unaudited)

(audited)

(unaudited)

£000

£000

£000

 

 

Financial assets

Financial assets at FVTPL

- Royalty finance investments

171,944

160,479

106,839

- Equity investments

11,305

10,820

4,870

183,249

171,299

111,709

Financial liabilities

Financial liabilities at FVTPL

- Royalty debt liabilities

1,125

1,111

1,076

 

The following table presents the changes in level 3 items for the periods ended 30 September 2022, 31 March 2022 and 30 September 2021:

 

Financial

 

Financial

 

 

Assets

 

Liabilities

 

Total

£000

 

£000

 

£000

 

 

At 31 March 2020

88,796

(1,031)

87,765

Additions

23,739

-

23,739

Repayments

(3,590)

-

(3,590)

Royalty income received

5,705

-

5,705

RP liability paid

-

57

57

Net change in FV

(2,941)

(102)

(3,043)

At 30 September 2021

111,709

(1,076)

110,633

Additions

51,377

-

51,377

Repayments

(2,232)

-

(2,232)

Royalty income received

(10,453)

-

(10,453)

RP liability paid

-

58

58

Net change in FV

21,000

(93)

20,907

At 31 March 2022

171,299

(1,111)

170,188

Additions

6,550

 

-

 

6,550

Repayments

-

 

-

 

-

Royalty income received

(15,079)

 

-

 

(15,079)

RP liability paid

-

 

57

 

57

Net change in FV

20,479

 

(71)

 

20,408

At 30 September 2022

183,249

 

(1,125)

 

182,124

 

 

Valuation techniques used to determine fair values

 

The fair value of the Group's financial instruments is determined using discounted cash flow analysis and all the resulting fair value estimates are included in level 3.

 

Valuation processes

 

The main level 3 inputs used by the Group are derived and evaluated as follows:

 

Annual adjustment factors for royalty investments and royalty participation liabilities

 

These factors are estimated based upon the underlying past and projected performance of the royalty investee companies together with general market conditions.

 

Discount rates for financial assets and liabilities

 

These are initially estimated based upon the projected internal rate of return of the royalty investment and subsequently adjusted to reflect changes in credit risk determined by the Group's Investment Committee.

 

Changes in level 3 fair values are analysed at the end of each reporting period and reasons for the fair value movements are documented.

 

Valuation inputs and relationships to fair value

 

The following summary outlines the quantitative information about the significant unobservable inputs used in level 3 fair value measurements:

 

Royalty investments

 

The unobservable inputs are the annual adjustment factor and the discount rate. The range of annual adjustment factors used is -6.0% to 6.0% and the range of risk-adjusted discount rates is 14.7% to 17.4%.

 

Equity investments

 

Sensitivity analysis has not been performed on the Group's equity investments on the basis that they are not material to the Condensed Consolidated Financial Statements

 

Royalty participation instruments

 

The unobservable inputs are the annual adjustment factor and the discount rate. The range of annual adjustment factors used is -6.0% to 6.0% and the range of risk-adjusted discount rates is 16.3% to 17.4%.

 

 

21. Events after the financial reporting date

 

Dividends

 

On 12 October 2022, the Company paid a quarterly dividend of 0.70 pence per share.

 

On 26 November, Duke announced a £5.5 million investment into New Path Fire & Security.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BMBPTMTBJBJT
Date   Source Headline
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company
5th Aug 20227:00 amRNSNotice of Results and Presentations
4th Aug 20227:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.